Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: PERPHENAZINE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Perphenazine submitted by Zydus Pharmaceuticals (USA) Inc. under ANDA205232, enabling a generic version of the a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)